Our founder, Yishai Knobel was featured by MM+M regarding his thoughts on the top trends in 2023. To quote his comments from the larger article:
“In 2023, forced to navigate trickier patient journeys and constrained marketing budgets, specialty patient services will be forced to rethink how to reach the 80% patients who never reach the Hub,” said RxWare CEO Yishai Knobel. “Patient journey continuity will become a key theme, and vendor interoperability will become table stakes in every RFP.”
Read the rest of the predictions at MM+T.